← Open Payments lookup

CHARLES TUAN-TU NGUYEN: Open Payments

NPI 1942380118 · IRVINE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$580,474 in 715 payments from 13 companies in 2025. Trend: 2023 $430,138 · 2024 $513,937 · 2025 $580,474

Speaker / faculty: $372,547Honoraria: $101,109Travel & lodging: $58,158Consulting: $33,712Food & beverage: $14,948
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.162$154,059
Otsuka America Pharmaceutical, Inc.193$152,531
Axsome Therapeutics, Inc.149$119,920
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)136$113,072
E.R. Squibb & Sons, L.L.C.53$39,792
Alkermes, Inc.9$511
Otsuka Pharmaceutical Development & Commercialization, Inc.5$380
Teva Pharmaceuticals USA, Inc.2$75
Lundbeck LLC2$47
ABBVIE INC.1$31

Products named: INGREZZA, Auvelity, CAPLYTA, REXULTI, ABILIFY MAINTENA, COBENFY, LYBALVI, ARISTADA.

Industry payments across CA — which companies pay providers there.